For a patient with a stage II‑III pressure ulcer that is clean, has minimal to moderate exudate, and no signs of infection, how should a hydrocolloid dressing be applied, how often should it be changed, and what are its contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydrocolloid Dressing for Stage II-III Pressure Ulcers

Use hydrocolloid dressings for clean stage II-III pressure ulcers with minimal to moderate exudate, changing them every 3-7 days or when the dressing becomes saturated, loses adhesion, or leaks. 1

Application Technique

Apply the hydrocolloid dressing to clean, dry skin with at least a 1-2 cm margin beyond the wound edge to ensure proper adhesion. The inner hydrocolloid adhesive layer absorbs exudate and forms a hydrated gel over the wound, creating a moist healing environment, while the outer layer seals the wound from bacterial contamination, urine, and feces 2. For sacral ulcers specifically, triangle-shaped hydrocolloid dressings applied point-down demonstrate superior wear time and healing compared to oval-shaped dressings 3.

Dressing Change Frequency

Change hydrocolloid dressings every 3-7 days under normal conditions 2. However, change the dressing sooner if:

  • The gel formation extends to the dressing edges (indicating saturation)
  • The dressing loses adhesion or begins to leak
  • Signs of infection develop
  • The patient is incontinent (which significantly reduces wear time) 3

The extended wear time is a key advantage—infrequent changes minimize disruption to the wound bed and reduce labor costs 4.

Contraindications and Cautions

Do not use hydrocolloid dressings when:

  • The wound is infected (contraindication)
  • Drainage is copious or heavy (hydrocolloids cannot manage high exudate volumes) 2
  • The wound is dry with minimal drainage (not cost-effective; consider alternatives) 2
  • The patient has known sensitivity to hydrocolloid materials 4

Important caveat: The gel formed by hydrocolloid dressings can have a yellow appearance and mild odor that may be mistaken for infection by inexperienced clinicians. This is normal and does not indicate infection unless accompanied by other signs (increased pain, erythema, warmth, purulent drainage) 2.

Evidence Quality

The American College of Physicians provides a weak recommendation based on low-quality evidence that hydrocolloid dressings reduce wound size better than gauze dressings and perform similarly to foam dressings for complete healing 1. More recent meta-analysis from 2023 shows hydrocolloids significantly improve complete healing rates for both stage II (OR 2.82) and stage III ulcers (OR 3.73) 5. The systematic review evidence confirms hydrocolloids are superior to gauze in absorption capacity, pain during changes, and side effects 6.

Adjunctive Measures

Consider adding protein/amino acid supplementation to reduce wound size 1 and electrical stimulation as adjunctive therapy to accelerate healing 1, both supported by ACP guidelines.

Related Questions

What is the term for a pressure ulcer that has progressed to a wound with undermining (Stage III pressure injury)?
What are appropriate treatment options for a large, erythematous pressure ulcer over the coccyx in an elderly hospice patient?
For a Stage 4 pressure ulcer with a deep cavity, exposed muscle, slough present, and moderate‑to‑heavy exudate, is a hydrocolloid dressing contraindicated, which dressing (e.g., high‑absorbent foam, alginate, or silver‑impregnated) is preferred, and when can hydrocolloid or collagen dressings be safely introduced?
How do I grade a pressure ulcer using the COPUR (Classification of Pressure‑Ulcer Risk) system?
What is the best dressing for a stage II pressure ulcer located under the buttocks?
Should I give famotidine (Pepcid) to a patient receiving steroids?
In a patient who has had a stroke and is found to have a persistent foramen ovale without evidence of deep‑vein thrombosis, which treatment is universally accepted?
What is the recommended use of Hepamerz (L‑ornithine‑L‑aspartate + pancreatin) for a patient with grade 2 non‑alcoholic fatty liver disease?
In an older adult with excess abdominal (visceral) fat, does the presence of this fat reduce muscle protein synthesis in response to a protein‑rich diet and resistance training?
In a patient with fatty liver disease graded 2 or higher, when is L‑ornithine‑L‑aspartate (LOLA) indicated and what is the recommended dosing?
What is the appropriate antibiotic treatment for a lactating woman with a urinary tract infection and mastitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.